Detalhe da pesquisa
1.
Efficacy and safety of tixagevimab-cilgavimab versus SARS-CoV-2 breakthrough infection in the hematological conditions.
Cancer
; 130(1): 41-50, 2024 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37658645
2.
Multicentric Castleman Disease and Concurrent Hematological Disorders: The Occurrence of Plasmacytoma and the Hypotheses Arising from Literature Review.
Acta Haematol
; 146(4): 331-337, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37068478
3.
Belantamab Mafodotin and Relapsed/Refractory Multiple Myeloma: This Is Not Game Over.
Acta Haematol
; 2021 Nov 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-34839282
4.
Younger patients with Waldenström Macroglobulinemia exhibit low risk profile and excellent outcomes in the era of immunotherapy and targeted therapies.
Am J Hematol
; 95(12): 1473-1478, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32780514
5.
Plasticity of High-Density Neutrophils in Multiple Myeloma is Associated with Increased Autophagy Via STAT3.
Int J Mol Sci
; 20(14)2019 Jul 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-32565533
6.
Lenalidomide plus Dexamethasone Combination as First-Line Oral Therapy of Multiple Myeloma Patients: A Unicentric Real-Life Study.
Cancers (Basel)
; 15(16)2023 Aug 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37627065
7.
Clinical outcome of SARS-CoV-2 infections occurring in multiple myeloma patients after vaccination and prophylaxis with tixagevimab/cilgavimab.
Front Oncol
; 13: 1157610, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37064138
8.
Lactate trafficking inhibition restores sensitivity to proteasome inhibitors and orchestrates immuno-microenvironment in multiple myeloma.
Cell Prolif
; 56(4): e13388, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36794373
9.
Multiple Myeloma in 2023 Ways: From Trials to Real Life.
Curr Oncol
; 30(11): 9710-9733, 2023 Nov 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37999125
10.
Reduced Absolute Count of Monocytes in Patients Carrying Hematological Neoplasms and SARS-CoV2 Infection.
Cancers (Basel)
; 14(5)2022 Feb 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-35267478
11.
CXCL12/CXCR4 axis supports mitochondrial trafficking in tumor myeloma microenvironment.
Oncogenesis
; 11(1): 6, 2022 Jan 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35064098
12.
Imatinib increases cytotoxicity of melphalan and their combination allows an efficient killing of chronic myeloid leukemia cells.
Eur J Haematol
; 86(3): 216-25, 2011 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-21198861
13.
Lenalidomide and Pomalidomide Improve Function and Induce FcγRI/CD64 in Multiple Myeloma Neutrophils.
Biomedicines
; 9(10)2021 Oct 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-34680570
14.
Role of Serum Free Light Chain Assay in Relapsed/Refractory Multiple Myeloma. A Real-Life Unicentric Retrospective Study.
Cancers (Basel)
; 13(23)2021 Nov 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-34885127
15.
Daratumumab as Single Agent in Relapsed/Refractory Myeloma Patients: A Retrospective Real-Life Survey.
Front Oncol
; 11: 624405, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33763359
16.
Influence of complex variant chromosomal translocations in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors.
Acta Oncol
; 49(4): 506-8, 2010 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-20331405
17.
Serum free light chains and multiple myeloma: Is it time to extend their application?
Clin Case Rep
; 8(4): 617-624, 2020 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-32274022
18.
Aberrant phenotypic expression of the T-cell-associated antigen CD8 on B-cell chronic lymphocytic leukemia cells.
Lab Hematol
; 15(1): 1-3, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-19273392
19.
A rare case of multiple myeloma with intracranial extramedullary relapse: One or more myeloma clones?
Clin Case Rep
; 7(9): 1629-1636, 2019 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-31534716
20.
Clinical Benefit of Long-Term Disease Control with Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients.
J Clin Med
; 8(10)2019 Oct 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-31623097